Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 240,000 shares of... Read more

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of Post-Acute COVID-19 Syndrome (PACS) PERTH, Australia–(BUSINESS WIRE)– A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute... Read more

Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board also Declares Quarterly Dividend

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2021, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 13, 2021. The share repurchase authorization permits shares to be repurchased... Read more

Roche to present data from one of the most comprehensive oncology portfolios at the 2021 ASCO Annual Meeting showcasing advancements for people living with cancer

Data from the first positive phase III study of a cancer immunotherapy in early, resected lung cancer Studies in personalised healthcare exploring tumour agnostic treatments that demonstrate the impact of coupling biomarker testing with targeted therapies to develop individualised treatment plans New data, and drug combination strategies for the treatment of lymphoma from the largest... Read more

GE Healthcare Introduces a New Virtual Solution with AI Enabled Applications For Precision Health in Nuclear Medicine

CHICAGO, 10 May 2021 – To help provide nuclear medicine clinicians greater flexibility and more time with patients, GE Healthcare today unveiled Xeleris V – a new virtual processing and review solution. Xeleris V eliminates the need for a standalone nuclear medicine workstation so that clinicians can have secure access to data from various locations.... Read more

Oxford Nanopore provides updated kits and protocols for rapid, scalable and low-cost sequencing of SARS-CoV-2 genomes

Wed 5th May 2021 Oxford Nanopore has released new protocols enabling the rapid, cost effective sequencing of SARS-CoV-2 — the virus that causes COVID-19. Research teams are able to access sequencing technology in days, without capital cost, for quick set-up of rapid turnaround SARS-CoV-2 sequencing.  From initial characterisation of the SARS-CoV-2 virus genome to the rapid identification of variants, researchers have been... Read more

Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories

Labs processing ~2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs BREA, CALIF., MAY. 4, 2021 — Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that... Read more

New Cypher VRS1250 Video-Rate Atomic Force Microscope Enables True Video-Rate Imaging at up to 45 Frames per Second

29 Apr April 27, 2021 (Santa Barbara, CA) Oxford Instruments Asylum Research today announced the launch of the new Cypher VRS1250 video-rate atomic force microscope (AFM). Twice as fast as the first-generation Cypher VRS, the new AFM enables scan rates up to 1250 lines/second and frame rates up to 45 frames/second. This new higher speed... Read more

Roche launches new ways to use their cardiovascular tests empowering clinicians to improve diagnosis and treatment of millions of people

Cardiovascular diseases are responsible for 17.9 million deaths every year¹, a third of all deaths globally² Roche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment Early diagnosis and treatment can contribute to saving or improving people’s lives and could help healthcare systems... Read more